Efficient scale-up and manufacture of mAbs for diagnostics
03 Dec 2021

Monoclonal antibodies (mAbs) are used extensively in the diagnostics industry, where their superior selectivity and binding greatly increases the robustness of such tests. 

In contrast to the manufacturing of therapeutic mAbs, where a single product is made in large batches, the diagnostic industry tends towards multiple products made in small volume batches.  This can create the perception that a scaled-up R&D process will be suitable for commercial production, both from a quality and economic standpoint. However, typically, this is not the case.

Key Learning Objectives:

Join this webinar to learn more about:

  • A commercial-scale approach to mAb production
  • Considerations for scale up
  • Large-scale production technologies

Who Should Attend?

  • Diagnostic test developers
  • In vitro diagnostics manufacturers
  • In vitro diagnostics QA/QC personnel

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

Merck